<?xml version="1.0" encoding="UTF-8"?>
<p>Current applications: the primary indication for chloroquine and hydroxychloroquine is to prevent or treat malaria and also in the treatment of several infections like HIV, Q fever, Whipple disease, and fungal infections. Other indications of these drugs include immunological and rheumatologic disorders like systemic lupus erythematosus (SLE), antiphospholipid antibody syndrome, rheumatoid arthritis, and Sjögren's syndrome. Chloroquine and hydroxychloroquine have been found to have anti-inflammatory, immunomodulating, anti-infective, antithrombotic, and metabolic effects. They also have an anti-tumoral effect because of their strong antiproliferative, antimutagenic, and inhibiting autophagy capacities [
 <xref rid="REF24" ref-type="bibr">24</xref>].
</p>
